Literature DB >> 1100089

Historical evidence for the genetic heterogeneity of pseudoxanthoma elasticum.

F M Pope.   

Abstract

Re-examination of published data from affected families with pseudoxanthoma elasticum (PXE) described in the literature between 1896 and 1968 supported the concept of clinical and genetic heterogeneity. There was clinical evidence for two autosomal dominant and one recessive type, although only a single patient with recessive type II was described. Examination of the individual pedigrees supported both autosomal dominant and recessive patterns of inheritance. The pooled genetic data were less helpful because they were so highly selected. (They had been reported in the literature.) Even so the dominant type II data fitted the hypothesis, whilst the type I and recessive groups were near the expected values. The clinical properties of the groups corresponded closely to the recent British (Pope, 1973) survey. In general, the dominant type I group showed classical cutaneous changes, vascular complications were common and the chief ophthalmic complication was a severe choroidoretinitis. The dominant type II group, in contrast, has an atypical macular rash, or sometimes no rash at all, no vascular complications and very mild retinal changes. Choroidoretinitis was rare and peau d'orange patterns and prominent choroidal vessels common. The recessive group was of intermediate severity.

Entities:  

Mesh:

Year:  1975        PMID: 1100089     DOI: 10.1111/j.1365-2133.1975.tb03117.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  18 in total

1.  Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter.

Authors:  F Ringpfeil; M G Lebwohl; A M Christiano; J Uitto
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 2.  [Pseudoxanthoma elasticum].

Authors:  M S Ladewig; C Götting; C Szliska; P C Issa; H-M Helb; I Bedenicki; H P N Scholl; F G Holz
Journal:  Ophthalmologe       Date:  2006-06       Impact factor: 1.059

Review 3.  ABCC6 and pseudoxanthoma elasticum.

Authors:  Arthur A B Bergen; Astrid S Plomp; Xiaofeng Hu; Paulus T V M de Jong; Theo G M F Gorgels
Journal:  Pflugers Arch       Date:  2006-04-08       Impact factor: 3.657

4.  Effect of selective enzymatic digestions on skin biopsies from pseudoxanthoma elasticum: an ultrastructural study.

Authors:  I Pasquali Ronchetti; M Baccarani Contri; C Pincelli; G M Bertazzoni
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

5.  Characterizing cutaneous elastic fibers by eosin fluorescence detected by fluorescence microscopy.

Authors:  Young Soo Heo; Hae Jun Song
Journal:  Ann Dermatol       Date:  2011-02-28       Impact factor: 1.444

6.  Pseudoxanthoma elasticum (Grönblad-Strandberg syndrome).

Authors:  D Viljoen
Journal:  J Med Genet       Date:  1988-07       Impact factor: 6.318

7.  Dark adaptation and scotopic perimetry over 'peau d'orange' in pseudoxanthoma elasticum.

Authors:  F G Holz; C Jubb; F W Fitzke; A C Bird; F M Pope
Journal:  Br J Ophthalmol       Date:  1994-01       Impact factor: 4.638

8.  An autopsy case of pseudoxanthoma elasticum: histochemical characteristics.

Authors:  Katsuaki Miki; Takashi Yuri; Nobuhiko Takeda; Kazuya Takehana; Toshiji Iwasaka; Airo Tsubura
Journal:  Med Mol Morphol       Date:  2007-09-18       Impact factor: 2.309

9.  Early preclinical diagnosis of dominant pseudoxanthoma elasticum by specific ultrastructural changes of dermal elastic and collagen tissue in a family at risk.

Authors:  I Hausser; I Anton-Lamprecht
Journal:  Hum Genet       Date:  1991-10       Impact factor: 4.132

10.  Matrix proteins with high affinity for calcium ions are associated with mineralization within the elastic fibers of pseudoxanthoma elasticum dermis.

Authors:  M B Contri; F Boraldi; F Taparelli; A De Paepe; I P Ronchetti
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.